About Us
About Carna
Management
Our Business
Products & Services
Products
Kinase Proteins and Other Protein Products
Assay Kits
Services
Activity-based Biochemical Screening/Profiling Assay Services
Cell-based Assay Services
Pricing & Technical Inquiry
Drug Discovery
Pipeline
Science
Technology
Partnering
Investors
News
Financial Reports/Presentations
Financial Highlights
IR Schedule
IR Contact
JP
EN
JP
EN
IR News
Investors
Investors
2019 IR News
IR News 2019
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Dec 20, 2019
ANNOUNCEMENT
Carna filed CTA in Europe for AS-0871
Nov 08, 2019
FINANCIALS
Financial Results FY2019Q3
Nov 08, 2019
FINANCIALS
Consolidated Financial Results for the Third Quarter of the Year Ending December 31, 2019
Aug 13, 2019
FINANCIALS
Financial Results FY2019 Q2
Jun 25, 2019
ANNOUNCEMENT
Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies
Jun 25, 2019
FINANCIALS
Revision of Results Forecast for the Fiscal Year Ending December 31, 2019
May 13, 2019
FINANCIALS
Financial Results FY2019 Q1
May 13, 2019
FINANCIALS
Financial Results FY2019 Q1
Feb 12, 2019
FINANCIALS
Financial Results FY2018
Feb 08, 2019
FINANCIALS
Consolidated Financial Results for the Year Ended December 31, 2018
Feb 04, 2019
ANNOUNCEMENT
Carna Announces Opening of New Clinical Development Office in South San Francisco
Jan 25, 2019
ANNOUNCEMENT
Carna Announces Publication in Scientific Reports Describing the Development of Novel Biosensors for Cell-Based Assay System
No IR News.
Investors Menu
News
Financial Reports/
Presentations
Financial Reports/
Presentations
Financial Highlights
IR Schedule
Contact IR
IR Contact
Email Alerts